Aspen sale sets hearts racing

Aspen Pharmacare sold its Thrombosis Business in Europe to US drugmaker Mylan to warm the hearts of shareholders fretting over the group’s R38 billion debt.

Aspen Pharmacare sold its Thrombosis Business in Europe to US drugmaker Mylan to warm the hearts of shareholders fretting over the group's R38 billion debt.

This article is exclusive to Biznews Premium. Members please login here. Not yet subscribed? Taste before you eat by signing up here for a half price 30 day trial (card details required).